Active ingredientPenbutololCat. No. P-P039-001CAS 36507-48-9Family · Pharmaceutical analytical standards
Penbutolol
A non-selective beta blocker with partial agonist (intrinsic sympathomimetic) activity, approved in the United States in 1987 for the treatment of mild to moderate hypertension. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?Besides beta receptors it also blocks the serotonin 5-HT1A and 5-HT1B receptors, like propranolol and pindolol, and it ranked second for lipophilicity in a comparison of 30 clinically used beta blockers.
Go to the active ingredient →Active ingredientPenbutololCat. No. P-P039-001CAS 36507-48-9
Active ingredientPenbutolol SulfateCat. No. P-P039-003CAS 38363-32-5
NitrosamineN-Nitroso rac-PenbutololCat. No. P-P039-007
Impurity4-Hydroxy PenbutololCat. No. P-P039-008
Impurityrac-Penbutolol HClCat. No. P-P039-009CAS 28163-36-2No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substancePenbutolol sulfate CRSEDQM code P0307000Family PenbutololNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.